We are analyzing https://link.springer.com/article/10.1007/s10549-009-0321-5.

Title:
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study | Breast Cancer Research and Treatment
Description:
Soy isoflavones, structurally similar to endogenous estrogens, may affect breast cancer through both hormonally mediated and non-hormonally related mechanisms. Although the effects of soy are not well understood, some breast cancer survivors increase their soy intake post-diagnosis in attempt to improve their prognosis. Therefore, we examined the role of soy isoflavone intake and the risk of breast cancer recurrence by hormone receptor status, menopausal status, and tamoxifen therapy. A cohort of 1,954 female breast cancer survivors, diagnosed during 1997–2000, was prospectively followed for 6.31 years and 282 breast cancer recurrences were ascertained. Isoflavone intake was assessed by mailing modified Block and supplemental soy food frequency questionnaires to participants, on average 23 months post-diagnosis. Risk of breast cancer recurrence, measured by hazard ratios (HR) and 95% confidence intervals (CI), was estimated using multivariable delayed entry Cox proportional hazards models. Suggestive trends for a reduced risk of cancer recurrence were observed with increasing quintiles of daidzein and glycetin intake compared to no intake among postmenopausal women (P for trend: P = 0.08 for daidzein, P = 0.06 for glycetin) and among tamoxifen users (P = 0.10 for daidzein, P = 0.05 for glycetin). Among postmenopausal women treated with tamoxifen, there was an approximately 60% reduction in breast cancer recurrence comparing the highest to the lowest daidzein intakes (>1,453 vs. <7.7 μg/day; HR, 0.48; 95% CI, 0.21–0.79, P = 0.008). Soy isoflavones consumed at levels comparable to those in Asian populations may reduce the risk of cancer recurrence in women receiving tamoxifen therapy and moreover, appears not to interfere with tamoxifen efficacy. Further confirmation is required in other large prospective studies before recommendations regarding soy intake can be issued to breast cancer survivors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, breast, google, scholar, article, pubmed, cas, soy, risk, study, intake, isoflavones, tamoxifen, women, research, recurrence, epidemiology, dietary, nutr, survivors, isoflavone, clin, content, caan, daidzein, dois, privacy, cookies, cohort, guha, effects, food, survival, natl, inst, res, questionnaire, california, publish, search, neela, kwan, quesenberry, frequency, access, consumption, patients, mammary, effect, usa,

Topics {✒️}

month download article/chapter cytochrome p450-mediated pathways average 23 months post-diagnosis administered food-frequency questionnaire plant-based dietary pattern wu-williams ah horn-ross pl soy food-frequency questionnaire national cancer institute soy intake post-diagnosis full article pdf prevent mammary tumours privacy choices/manage cookies breast cancer patients related subjects female patients tend food frequency questionnaire hormonally related mechanisms breast cancer survivors ethnic chinese women european economic area 2007 dor/chr fellow breast cancer recurrence affect breast cancer breast cancer diagnosis breast cancer subtypes plasma isoflavone concentrations article guha breast cancer incidence institutional soy foods data-based approach capita food consumption mailing modified block iarc scientific publications hypothalamic/pituitary axis van breemen rb primary tumor sites pierce jp perez-stable ej local postmenopause receptors breast cancer risk soy isoflavones consumed breast cancer relationship conditions privacy policy lowest daidzein intakes breast cancer survival soy isoflavone intake assess isoflavone intake estimating usual intake large prospective studies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study
         description:Soy isoflavones, structurally similar to endogenous estrogens, may affect breast cancer through both hormonally mediated and non-hormonally related mechanisms. Although the effects of soy are not well understood, some breast cancer survivors increase their soy intake post-diagnosis in attempt to improve their prognosis. Therefore, we examined the role of soy isoflavone intake and the risk of breast cancer recurrence by hormone receptor status, menopausal status, and tamoxifen therapy. A cohort of 1,954 female breast cancer survivors, diagnosed during 1997–2000, was prospectively followed for 6.31 years and 282 breast cancer recurrences were ascertained. Isoflavone intake was assessed by mailing modified Block and supplemental soy food frequency questionnaires to participants, on average 23 months post-diagnosis. Risk of breast cancer recurrence, measured by hazard ratios (HR) and 95% confidence intervals (CI), was estimated using multivariable delayed entry Cox proportional hazards models. Suggestive trends for a reduced risk of cancer recurrence were observed with increasing quintiles of daidzein and glycetin intake compared to no intake among postmenopausal women (P for trend: P = 0.08 for daidzein, P = 0.06 for glycetin) and among tamoxifen users (P = 0.10 for daidzein, P = 0.05 for glycetin). Among postmenopausal women treated with tamoxifen, there was an approximately 60% reduction in breast cancer recurrence comparing the highest to the lowest daidzein intakes (>1,453 vs. <7.7 μg/day; HR, 0.48; 95% CI, 0.21–0.79, P = 0.008). Soy isoflavones consumed at levels comparable to those in Asian populations may reduce the risk of cancer recurrence in women receiving tamoxifen therapy and moreover, appears not to interfere with tamoxifen efficacy. Further confirmation is required in other large prospective studies before recommendations regarding soy intake can be issued to breast cancer survivors.
         datePublished:2009-02-17T00:00:00Z
         dateModified:2009-02-17T00:00:00Z
         pageStart:395
         pageEnd:405
         sameAs:https://doi.org/10.1007/s10549-009-0321-5
         keywords:
            Breast neoplasms
            Daidzein
            Genistein
            Isoflavones
            Neoplasm recurrence, local
            Postmenopause
            Receptors, estrogen
            Soy foods
            Tamoxifen
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0321-5/MediaObjects/10549_2009_321_Fig1_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:118
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Neela Guha
               affiliation:
                     name:University of California
                     address:
                        name:Department of Epidemiology, University of California, Berkeley, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Marilyn L. Kwan
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charles P. Quesenberry
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Erin K. Weltzien
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adrienne L. Castillo
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bette J. Caan
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study
      description:Soy isoflavones, structurally similar to endogenous estrogens, may affect breast cancer through both hormonally mediated and non-hormonally related mechanisms. Although the effects of soy are not well understood, some breast cancer survivors increase their soy intake post-diagnosis in attempt to improve their prognosis. Therefore, we examined the role of soy isoflavone intake and the risk of breast cancer recurrence by hormone receptor status, menopausal status, and tamoxifen therapy. A cohort of 1,954 female breast cancer survivors, diagnosed during 1997–2000, was prospectively followed for 6.31 years and 282 breast cancer recurrences were ascertained. Isoflavone intake was assessed by mailing modified Block and supplemental soy food frequency questionnaires to participants, on average 23 months post-diagnosis. Risk of breast cancer recurrence, measured by hazard ratios (HR) and 95% confidence intervals (CI), was estimated using multivariable delayed entry Cox proportional hazards models. Suggestive trends for a reduced risk of cancer recurrence were observed with increasing quintiles of daidzein and glycetin intake compared to no intake among postmenopausal women (P for trend: P = 0.08 for daidzein, P = 0.06 for glycetin) and among tamoxifen users (P = 0.10 for daidzein, P = 0.05 for glycetin). Among postmenopausal women treated with tamoxifen, there was an approximately 60% reduction in breast cancer recurrence comparing the highest to the lowest daidzein intakes (>1,453 vs. <7.7 μg/day; HR, 0.48; 95% CI, 0.21–0.79, P = 0.008). Soy isoflavones consumed at levels comparable to those in Asian populations may reduce the risk of cancer recurrence in women receiving tamoxifen therapy and moreover, appears not to interfere with tamoxifen efficacy. Further confirmation is required in other large prospective studies before recommendations regarding soy intake can be issued to breast cancer survivors.
      datePublished:2009-02-17T00:00:00Z
      dateModified:2009-02-17T00:00:00Z
      pageStart:395
      pageEnd:405
      sameAs:https://doi.org/10.1007/s10549-009-0321-5
      keywords:
         Breast neoplasms
         Daidzein
         Genistein
         Isoflavones
         Neoplasm recurrence, local
         Postmenopause
         Receptors, estrogen
         Soy foods
         Tamoxifen
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-009-0321-5/MediaObjects/10549_2009_321_Fig1_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:118
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Neela Guha
            affiliation:
                  name:University of California
                  address:
                     name:Department of Epidemiology, University of California, Berkeley, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Marilyn L. Kwan
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charles P. Quesenberry
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Erin K. Weltzien
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adrienne L. Castillo
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bette J. Caan
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:118
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California
      address:
         name:Department of Epidemiology, University of California, Berkeley, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Neela Guha
      affiliation:
            name:University of California
            address:
               name:Department of Epidemiology, University of California, Berkeley, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Marilyn L. Kwan
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      name:Charles P. Quesenberry
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      name:Erin K. Weltzien
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      name:Adrienne L. Castillo
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      name:Bette J. Caan
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Epidemiology, University of California, Berkeley, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(195)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.57s.

LINK . SPRINGER . COM {}